Achieve Life Sciences (ACHV) Operating Margin (2010 - 2012)
Achieve Life Sciences' (ACHV) quarterly Operating Margin came in at 126.18% in Q3 2012, down 22280.0% YoY from N/an in Q4 2011, and down 48.44% on a QoQ basis from 244.71% in Q2 2012.
Achieve Life Sciences (ACHV) Operating Margin (2010 - 2012) Analysis & Trends
Achieve Life Sciences (ACHV) has 3 years of Operating Margin data on file, last reported at 126.18% in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 126.18% |
| Jun 30, 2012 | 244.71% |
| Mar 31, 2012 | -418.16% |
| Sep 30, 2011 | 348.98% |
| Jun 30, 2011 | 264.60% |
| Mar 31, 2011 | -435.78% |
| Sep 30, 2010 | -142.33% |
| Jun 30, 2010 | -167.72% |